Intech Investment Management LLC Purchases 25,735 Shares of STERIS plc $STE

Key Points

• Intech Investment Management LLC increased its STERIS stake by 58.2% in the fourth quarter, buying 25,735 additional shares and bringing its total holdings to 69,968 shares worth about $17.7 million.
• STERIS shares were up 1.3% to $215.54, but the stock remains below its 200-day moving average and well under its 12-month high of $269.44.
• The company reported quarterly EPS of $2.83, slightly missing analyst estimates, while revenue matched expectations at $1.59 billion and rose 6.7% year over year; STERIS also declared a $0.63 quarterly dividend.

Intech Investment Management LLC boosted its position in shares of STERIS plc (NYSE:STE - Free Report) by 58.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,968 shares of the medical equipment provider's stock after acquiring an additional 25,735 shares during the period. Intech Investment Management LLC owned 0.07% of STERIS worth $17,738,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Trust Co. of Vermont grew its position in shares of STERIS by 30.2% during the 4th quarter. Trust Co. of Vermont now owns 164 shares of the medical equipment provider's stock valued at $42,000 after purchasing an additional 38 shares in the last quarter. Bailard Inc. raised its position in shares of STERIS by 3.5% in the fourth quarter. Bailard Inc. now owns 1,118 shares of the medical equipment provider's stock worth $283,000 after buying an additional 38 shares in the last quarter. Magnolia Capital Advisors LLC boosted its stake in STERIS by 1.2% during the third quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider's stock valued at $888,000 after buying an additional 41 shares during the period. Colonial Trust Co SC boosted its stake in STERIS by 0.3% during the third quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider's stock valued at $3,051,000 after buying an additional 42 shares during the period. Finally, Geneos Wealth Management Inc. grew its position in STERIS by 34.9% during the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider's stock worth $42,000 after buying an additional 45 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Trading Up 1.3%

Shares of STE stock opened at $215.54 on Friday. The business has a 50-day moving average price of $218.32 and a two-hundred day moving average price of $241.13. STERIS plc has a 12-month low of $195.14 and a 12-month high of $269.44. The company has a quick ratio of 1.54, a current ratio of 2.09 and a debt-to-equity ratio of 0.25. The firm has a market cap of $21.14 billion, a P/E ratio of 27.18 and a beta of 0.95.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing analysts' consensus estimates of $2.86 by ($0.03). The firm had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The business's quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities analysts anticipate that STERIS plc will post 11.18 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be issued a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Monday, June 8th. STERIS's payout ratio is presently 31.78%.

Insider Buying and Selling at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the company's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the sale, the director owned 705 shares of the company's stock, valued at approximately $167,233.05. This represents a 81.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.07% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Wall Street Zen raised STERIS from a "buy" rating to a "strong-buy" rating in a report on Saturday, May 16th. Weiss Ratings cut shares of STERIS from a "hold (c+)" rating to a "hold (c)" rating in a research report on Wednesday. KeyCorp lowered their target price on shares of STERIS from $291.00 to $269.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 13th. Finally, Piper Sandler reiterated an "overweight" rating and set a $270.00 target price on shares of STERIS in a research report on Thursday, May 21st. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and a consensus price target of $278.00.

About STERIS

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.